AFJK Market Analysis

Overview

Fundamentals

P/E ratio230.90
EPS (TTM)$0.20-30.2% YoY
Profit margin0.0%FINANCIAL SERVICES
Market cap$282.7MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
6.73
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
-1.50
Last earnings
Nov 18, 2025 · Reported $0.06
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 2 · 21 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Aimei Health Technology Co., Ltd Ordinary Share

Aimei Health Technology Co., Ltd. is an innovative leader in the healthcare technology sector, focused on transforming health solutions through cutting-edge digital platforms and medical devices. The company is at the forefront of the burgeoning telehealth and personalized medicine markets, utilizing advanced artificial intelligence and data analytics to improve patient outcomes and optimize healthcare delivery. Aimei's strategic commitment to innovation not only enhances operational efficiency within healthcare systems but also positions the company for significant growth and a pivotal role…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
10 EAST 53RD STREET, NEW YORK, NY
Fiscal year end
December
Latest quarter
Sep 30, 2025
Market cap$282.7M
Shares outstanding$6.1M
52W high$130.37
52W low$6.75

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer